It is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps to lower blood sugar levels by increasing insulin secretion, decreasing glucagon secretion, and slowing gastric emptying
Regarding safety profile, in phase 2 trials for obesity and diabetes, mazdutide was discontinued due to AE by 02% of participants and SAE experienced by up to 7% of participants with mazdutide 6 mg (Tables 2 and 3)
Diet, aging, environmental factors, and circumstances can all affect our ability to maximize the nourishment we need
The appointment takes just a few minutes, and you can return to your day immediately afterward
This slow titration is part of why Saxenda is well tolerated
weight loss ~15% over 68 wks Dual GIP / GLP-1 Not included Tirzepatide GLP-1 from $349/mo, any dose Receptor GLP-1 + GIP Dosing Once weekly Format Self-injection Avg